# Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome

> **NCT06814626** · PHASE3 · RECRUITING · sponsor: **The Mediterranean Institute for Transplantation and Advanced Specialized Therapies** · enrollment: 72 (estimated)

## Conditions studied

- Liver Cirrhosis
- Refractory Ascites in Patients with Cirrhosis
- Sarcopenia in Liver Cirrhosis

## Interventions

- **DIETARY_SUPPLEMENT:** 12-week nutritional intervention with Friliver dispensing
- **OTHER:** 12-week nutritional intervention with personalized diet
- **OTHER:** 12-week nutritional intervention with diet diary to report foods eaten.

## Key facts

- **NCT ID:** NCT06814626
- **Lead sponsor:** The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-13
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814626, "Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06814626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*